Back
Synchrony Financial Vs. Novo Nordisk AS Industry Stock Comparison
Buy
74
SYF
Synchrony Financial
Last Price:
$65.47
Seasonality Move:
-4.94%
Sell
29
NVO
Novo Nordisk AS
Last Price:
$86.02
Seasonality Move:
6.4%
Buy
74
Synchrony Financial (SYF)
is a Buy
Is Synchrony Financial a Buy, Sell or Hold?
-
The current Synchrony Financial [SYF] share price is $65.00. The Score for SYF is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
-
SYF is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
29
Novo Nordisk AS (NVO)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NVO] share price is $86.02. The Score for NVO is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
-
NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SYF Stock Price Chart
What is Synchrony Financial's stock price today?
-
The Synchrony Financial share price today is $65.00The current trend is moderately bearish and SYF is experiencing slight selling pressure.
NVO Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $86.02Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing buying pressure, which is a positive indicator for future bullish movement.
SYF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.37 | Buy |
Relative Strength Index (14 RSI): | 47.59 | Sell |
Chaikin Money Flow: | -481576 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (65.46 - 68.04) | Sell |
Bollinger Bands (100): | (48.23 - 64.55) | Buy |
NVO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -6.1 | Sell |
Relative Strength Index (14 RSI): | 26.04 | Sell |
Chaikin Money Flow: | 3954400 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (92.37 - 111.71) | Sell |
Bollinger Bands (100): | (102.88 - 130.98) | Sell |
SYF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 65.57 | Sell |
20-day SMA: | 66.63 | Sell |
50-day SMA: | 63.63 | Buy |
200-day SMA: | 50.57 | Buy |
8-day EMA: | 65.72 | Sell |
20-day EMA: | 65.9 | Sell |
50-day EMA: | 63.15 | Buy |
200-day EMA: | 52.38 | Buy |
NVO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 88.91 | Sell |
20-day SMA: | 100.93 | Sell |
50-day SMA: | 105.5 | Sell |
200-day SMA: | 124.86 | Sell |
8-day EMA: | 90.16 | Sell |
20-day EMA: | 97.16 | Sell |
50-day EMA: | 105.13 | Sell |
200-day EMA: | 116.29 | Sell |
Synchrony Financial Earnings Growth & SYF Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and an increase next year of $1.04 per share.
Novo Nordisk AS Earnings Growth & NVO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.72 per share, and an increase next year of $0.66 per share.
Synchrony Financial Technical Analysis
Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
17 | 18 | 19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novo Nordisk AS Technical Analysis
Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
17 | 18 | 19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |